Nabil Chehab, Lung Cancer Medical Franchise Head and Executive Medical Director, US Medical Affairs at AstraZeneca, shared on LinkedIn:
“For many people living with cancer, treatment can mean repeated cycles of therapy, uncertainty and ongoing disruption to daily life. That’s why I’m pleased to see our latest What Science Can Do blog focus not only on scientific innovation driving progress in cell therapy, but also the efforts to reduce burden and improving access for patients․
It’s meaningful to be part of AstraZeneca, where we are working to advance next-generation cell therapies and improve how these treatments may reach patients.”
